Literature DB >> 29059430

Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.

Lindsay M Morton1, Joshua N Sampson1, Gregory T Armstrong1, Ting-Huei Chen1, Melissa M Hudson1, Eric Karlins1, Casey L Dagnall1, Shengchao Alfred Li1, Carmen L Wilson1, Deo Kumar Srivastava1, Wei Liu1, Guolian Kang1, Kevin C Oeffinger1, Tara O Henderson1, Chaya S Moskowitz1, Todd M Gibson1, Diana M Merino1, Jeannette R Wong1, Sue Hammond1, Joseph P Neglia1, Lucie M Turcotte1, Jeremy Miller1, Laura Bowen1, William A Wheeler1, Wendy M Leisenring1, John A Whitton1, Laurie Burdette1, Charles Chung1, Belynda D Hicks1, Kristine Jones1, Mitchell J Machiela1, Aurelie Vogt1, Zhaoming Wang1, Meredith Yeager1, Geoffrey Neale1, Matthew Lear1, Louise C Strong1, Yutaka Yasui1, Marilyn Stovall1, Rita E Weathers1, Susan A Smith1, Rebecca Howell1, Stella M Davies1, Gretchen A Radloff1, Kenan Onel1, Amy Berrington de González1, Peter D Inskip1, Preetha Rajaraman1, Joseph F Fraumeni1, Smita Bhatia1, Stephen J Chanock1, Margaret A Tucker1, Leslie L Robison1.   

Abstract

Background: Childhood cancer survivors treated with chest-directed radiotherapy have substantially elevated risk for developing breast cancer. Although genetic susceptibility to breast cancer in the general population is well studied, large-scale evaluation of breast cancer susceptibility after chest-directed radiotherapy for childhood cancer is lacking.
Methods: We conducted a genome-wide association study of breast cancer in female survivors of childhood cancer, pooling two cohorts with detailed treatment data and systematic, long-term follow-up: the Childhood Cancer Survivor Study and St. Jude Lifetime Cohort. The study population comprised 207 survivors who developed breast cancer and 2774 who had not developed any subsequent neoplasm as of last follow-up. Genotyping and subsequent imputation yielded 16 958 466 high-quality variants for analysis. We tested associations in the overall population and in subgroups stratified by receipt of lower than 10 and 10 or higher gray breast radiation exposure. We report P values and pooled per-allele risk estimates from Cox proportional hazards regression models. All statistical tests were two-sided.
Results: Among survivors who received 10 or higher gray breast radiation exposure, a locus on 1q41 was associated with subsequent breast cancer risk (rs4342822, nearest gene PROX1 , risk allele frequency in control subjects [RAF controls ] = 0.46, hazard ratio = 1.92, 95% confidence interval = 1.49 to 2.44, P = 7.09 × 10 -9 ). Two rare variants also showed potentially promising associations (breast radiation ≥10 gray: rs74949440, 11q23, TAGLN , RAF controls = 0.02, P = 5.84 × 10 -8 ; <10 gray: rs17020562, 1q32.3, RPS6KC1 , RAF controls = 0.0005, P = 6.68 × 10 -8 ). Associations were restricted to these dose subgroups, with consistent findings in the two survivor cohorts. Conclusions: Our study provides strong evidence that germline genetics outside high-risk syndromes could modify the effect of radiation exposure on breast cancer risk after childhood cancer. Published by Oxford University Press 2017. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29059430      PMCID: PMC6059172          DOI: 10.1093/jnci/djx058

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  36 in total

1.  Dose reconstruction for therapeutic and diagnostic radiation exposures: use in epidemiological studies.

Authors:  Marilyn Stovall; Rita Weathers; Catherine Kasper; Susan A Smith; Lois Travis; Elaine Ron; Ruth Kleinerman
Journal:  Radiat Res       Date:  2006-07       Impact factor: 2.841

2.  CTCF negatively regulates HOXA10 expression in breast cancer cells.

Authors:  Muhammad Mustafa; Ji-Yeon Lee; Myoung Hee Kim
Journal:  Biochem Biophys Res Commun       Date:  2015-10-23       Impact factor: 3.575

Review 3.  Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer.

Authors:  Tara O Henderson; Alison Amsterdam; Smita Bhatia; Melissa M Hudson; Anna T Meadows; Joseph P Neglia; Lisa R Diller; Louis S Constine; Robert A Smith; Martin C Mahoney; Elizabeth A Morris; Leslie L Montgomery; Wendy Landier; Stephanie M Smith; Leslie L Robison; Kevin C Oeffinger
Journal:  Ann Intern Med       Date:  2010-04-06       Impact factor: 25.391

4.  Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma.

Authors:  Timothy Best; Dalin Li; Andrew D Skol; Tomas Kirchhoff; Sarah A Jackson; Yutaka Yasui; Smita Bhatia; Louise C Strong; Susan M Domchek; Katherine L Nathanson; Olufunmilayo I Olopade; R Stephanie Huang; Thomas M Mack; David V Conti; Kenneth Offit; Wendy Cozen; Leslie L Robison; Kenan Onel
Journal:  Nat Med       Date:  2011-07-24       Impact factor: 53.440

5.  Radiation dose and breast cancer risk in the childhood cancer survivor study.

Authors:  Peter D Inskip; Leslie L Robison; Marilyn Stovall; Susan A Smith; Sue Hammond; Ann C Mertens; John A Whitton; Lisa Diller; Lisa Kenney; Sarah S Donaldson; Anna T Meadows; Joseph P Neglia
Journal:  J Clin Oncol       Date:  2009-07-20       Impact factor: 44.544

6.  Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer.

Authors:  Beatrix Versmold; Jörg Felsberg; Thomas Mikeska; Denise Ehrentraut; Juliane Köhler; Juergen A Hampl; Gabriele Röhn; Dieter Niederacher; Beate Betz; Martin Hellmich; Torsten Pietsch; Rita K Schmutzler; Andreas Waha
Journal:  Int J Cancer       Date:  2007-08-01       Impact factor: 7.396

7.  Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Authors:  Renée L Mulder; Leontien C M Kremer; Melissa M Hudson; Smita Bhatia; Wendy Landier; Gill Levitt; Louis S Constine; W Hamish Wallace; Flora E van Leeuwen; Cécile M Ronckers; Tara O Henderson; Mary Dwyer; Roderick Skinner; Kevin C Oeffinger
Journal:  Lancet Oncol       Date:  2013-12       Impact factor: 41.316

8.  Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.

Authors:  Debra L Friedman; John Whitton; Wendy Leisenring; Ann C Mertens; Sue Hammond; Marilyn Stovall; Sarah S Donaldson; Anna T Meadows; Leslie L Robison; Joseph P Neglia
Journal:  J Natl Cancer Inst       Date:  2010-07-15       Impact factor: 11.816

9.  PTPRN2 and PLCβ1 promote metastatic breast cancer cell migration through PI(4,5)P2-dependent actin remodeling.

Authors:  Caitlin A Sengelaub; Kristina Navrazhina; Jason B Ross; Nils Halberg; Sohail F Tavazoie
Journal:  EMBO J       Date:  2015-11-30       Impact factor: 11.598

10.  PROX1 gene is differentially expressed in oral cancer and reduces cellular proliferation.

Authors:  Maria F S D Rodrigues; Camila de Oliveira Rodini; Flávia C de Aquino Xavier; Katiúcia B Paiva; Patrícia Severino; Raquel A Moyses; Rossana M López; Rafael DeCicco; Lília A Rocha; Marcos B Carvalho; Eloiza H Tajara; Fabio D Nunes
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

View more
  32 in total

1.  Radiogenomic Predictors of Adverse Effects following Charged Particle Therapy.

Authors:  Lindsay M Morton; Luisel Ricks-Santi; Catharine M L West; Barry S Rosenstein
Journal:  Int J Part Ther       Date:  2018-09-21

2.  Clinical Benefits, Harms, and Cost-Effectiveness of Breast Cancer Screening for Survivors of Childhood Cancer Treated With Chest Radiation : A Comparative Modeling Study.

Authors:  Jennifer M Yeh; Kathryn P Lowry; Clyde B Schechter; Lisa R Diller; Oguzhan Alagoz; Gregory T Armstrong; John M Hampton; Wendy Leisenring; Qi Liu; Jeanne S Mandelblatt; Diana L Miglioretti; Chaya S Moskowitz; Kevin C Oeffinger; Amy Trentham-Dietz; Natasha K Stout
Journal:  Ann Intern Med       Date:  2020-07-07       Impact factor: 25.391

3.  Prox1 inhibits neurite outgrowth during central nervous system development.

Authors:  Valeria Kaltezioti; Iosifina P Foskolou; Matthieu D Lavigne; Elpinickie Ninou; Matina Tsampoula; Maria Fousteri; Marigoula Margarity; Panagiotis K Politis
Journal:  Cell Mol Life Sci       Date:  2020-11-28       Impact factor: 9.261

4.  A High-risk Haplotype for Premature Menopause in Childhood Cancer Survivors Exposed to Gonadotoxic Therapy.

Authors:  Russell J Brooke; Cindy Im; Carmen L Wilson; Matthew J Krasin; Qi Liu; Zhenghong Li; Yadav Sapkota; WonJong Moon; Lindsay M Morton; Gang Wu; Zhaoming Wang; Wenan Chen; Rebecca M Howell; Gregory T Armstrong; Smita Bhatia; Sogol Mostoufi-Moab; Kristy Seidel; Stephen J Chanock; Jinghui Zhang; Daniel M Green; Charles A Sklar; Melissa M Hudson; Leslie L Robison; Wassim Chemaitilly; Yutaka Yasui
Journal:  J Natl Cancer Inst       Date:  2018-08-01       Impact factor: 13.506

Review 5.  The Future of Childhood Cancer Survivorship: Challenges and Opportunities for Continued Progress.

Authors:  Stephanie B Dixon; Eric J Chow; Lars Hjorth; Melissa M Hudson; Leontien C M Kremer; Lindsay M Morton; Paul C Nathan; Kirsten K Ness; Kevin C Oeffinger; Gregory T Armstrong
Journal:  Pediatr Clin North Am       Date:  2020-12       Impact factor: 3.278

Review 6.  New Agents, Emerging Late Effects, and the Development of Precision Survivorship.

Authors:  Eric J Chow; Zoltan Antal; Louis S Constine; Rebecca Gardner; W Hamish Wallace; Brent R Weil; Jennifer M Yeh; Elizabeth Fox
Journal:  J Clin Oncol       Date:  2018-06-06       Impact factor: 44.544

Review 7.  Risk, Risk Factors, and Surveillance of Subsequent Malignant Neoplasms in Survivors of Childhood Cancer: A Review.

Authors:  Lucie M Turcotte; Joseph P Neglia; Raoul C Reulen; Cecile M Ronckers; Flora E van Leeuwen; Lindsay M Morton; David C Hodgson; Yutaka Yasui; Kevin C Oeffinger; Tara O Henderson
Journal:  J Clin Oncol       Date:  2018-06-06       Impact factor: 44.544

Review 8.  Current and coming challenges in the management of the survivorship population.

Authors:  Eric J Chow; Kirsten K Ness; Gregory T Armstrong; Nickhill Bhakta; Jennifer M Yeh; Smita Bhatia; Wendy Landier; Louis S Constine; Melissa M Hudson; Paul C Nathan
Journal:  Semin Oncol       Date:  2020-03-04       Impact factor: 4.929

9.  Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.

Authors:  Lisa Mirabello; Bin Zhu; Roelof Koster; Eric Karlins; Michael Dean; Meredith Yeager; Matthew Gianferante; Logan G Spector; Lindsay M Morton; Danielle Karyadi; Leslie L Robison; Gregory T Armstrong; Smita Bhatia; Lei Song; Nathan Pankratz; Maisa Pinheiro; Julie M Gastier-Foster; Richard Gorlick; Silvia Regina Caminada de Toledo; Antonio S Petrilli; Ana Patino-Garcia; Fernando Lecanda; Miriam Gutierrez-Jimeno; Massimo Serra; Claudia Hattinger; Piero Picci; Katia Scotlandi; Adrienne M Flanagan; Roberto Tirabosco; Maria Fernanda Amary; Nilgün Kurucu; Inci Ergurhan Ilhan; Mandy L Ballinger; David M Thomas; Donald A Barkauskas; Gerardo Mejia-Baltodano; Patricia Valverde; Belynda D Hicks; Bin Zhu; Mingyi Wang; Amy A Hutchinson; Margaret Tucker; Joshua Sampson; Maria T Landi; Neal D Freedman; Susan Gapstur; Brian Carter; Robert N Hoover; Stephen J Chanock; Sharon A Savage
Journal:  JAMA Oncol       Date:  2020-05-01       Impact factor: 31.777

Review 10.  Adolescent and young adult Hodgkin lymphoma: Raising the bar through collaborative science and multidisciplinary care.

Authors:  Justine M Kahn; Kara M Kelly
Journal:  Pediatr Blood Cancer       Date:  2018-03-30       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.